Medisi America
  • Home
  • We Are
  • Services
  • News
  • Contact Us
 

COFEPRIS Evolves

24 agosto, 2020
 

COFEPRIS Challenges 2020

21 febrero, 2020

Since December 1st, 2018 a historical change in administration that consisted of a new president who is committed to Public Office cleansing of corrupt and unequal practices had a strong impact on the whole country course of operation. Many institutions were eliminated or were audited and restructured.  Cofepris was audited and analyzed for permanence or …

 

ResMed ventilators recall is Class I

19 febrero, 2020

FDA today designated a ResMed (NYSE:RMD) recall of certain Stellar non-invasive and invasive ventilators as Class I — the agency’s most serious level. The sound alarm on the ventilators may not work if the device has a failed electronic part, is stored without AC power for more than 36 hours, or powers on automatically when connected …

Older Posts

Entradas recientes

  • COFEPRIS Evolves
  • COFEPRIS Challenges 2020
  • ResMed ventilators recall is Class I
  • Finding a non-invasive way to predict effectiveness of cancer therapy.

NEWS

  • Conferences
  • News
  • Science
  • Technology
  • © 2023 MEDISI America - All rights reserved
  • Home
  • We Are
  • Services
  • News
  • Contact Us